Date Field | Doc. No. | Party | Description |
---|
Jan 20, 2023 | 0 | petitioner | Download |
Apr 16, 2021 | 1 | petitioner | PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 9,220,631 Download |
Apr 16, 2021 | 2 | petitioner | POWER OF ATTORNEY FOR PETITIONER REGENERON PHARMACEUTICALS, INC. Download |
Apr 28, 2021 | 3 | board | Notice of Accord Filing Date Download |
May 7, 2021 | 4 | patent_own | Download |
May 7, 2021 | 5 | patent_own | Patent Owner Novartis Pharma AG's Power of Attorney Download |
May 7, 2021 | 6 | patent_own | Patent Owner Novartis Pharmaceutical Corporation's Power of Attorney Download |
May 7, 2021 | 7 | patent_own | Patent Owner Novartis Technology LLC's Power of Attorney Download |
Jul 28, 2021 | 8 | patent_own | Download |
Jul 28, 2021 | 9 | patent_own | Download |
Jul 28, 2021 | 10 | patent_own | Download |
Aug 20, 2021 | 11 | petitioner | Petitioner's Reply to Patent Owner's Preliminary Response Download |
Aug 27, 2021 | 12 | patent_own | Download |
Oct 26, 2021 | 13 | board | Institution Decision: Grant Download |
Oct 26, 2021 | 14 | board | Order: Scheduling Order Download |
Oct 28, 2021 | 15 | board | ORDER Denying Patent Owners Motion to Seal 37 C.F.R. sec s 42.14 and 42.54 Download |
Nov 9, 2021 | 16 | petitioner | Petitioner's Objections to Admissibility of Evidence Submitted by Patent Owner Download |
Nov 9, 2021 | 17 | patent_own | Patent Owners Objections to Admissibility of Evidence Submitted by Petitioners Download |
Nov 19, 2021 | 18 | patent_own | Patent Owners Second Motion to Seal Download |
Nov 19, 2021 | 19 | patent_own | Patent Owners Updated Exhibit List Download |
Nov 23, 2021 | 20 | petitioner | Petitioner's Notice of Supplemental Evidence Download |
Nov 23, 2021 | 21 | petitioner | Petitioner's First Supplemental Exhibit List Download |
Nov 30, 2021 | 22 | board | Order: Granting Patent Owner's Second Motion to Seal - 37 CFR 42.14 and 42.54 Download |
Dec 2, 2021 | 23 | patent_own | Patent Owners' Notice of Deposition of Horst Koller Under C.F.R. Section 42.53 Download |
Dec 3, 2021 | 24 | petitioner | Petitioner's Corrected First Supplemental Exhibit List Download |
Dec 22, 2021 | 25 | patent_own | Patent Owners Motion for Pro Hac Vice Admission of Nicholas K. Mitrokostas Under 37 C.F.R. Section 42.10(c) Download |
Dec 22, 2021 | 26 | patent_own | Patent Owners Updated Exhibit List Download |
Dec 22, 2021 | 27 | petitioner | Motion: PHV Download |
Dec 22, 2021 | 28 | petitioner | Notice: exhibit list Download |
Dec 23, 2021 | 29 | patent_own | Patent Owners Notice of Deposition of Szilard Kiss Under C.F.R. Section 42.53 Download |
Jan 5, 2022 | 30 | board | Order: Granting Patent Owner's Motion for Admission Pro Hac Vice of Nicholas K. Mitrokostas Download |
Jan 5, 2022 | 31 | board | Order: Granting Petitioner's Motion for Admission Pro Hac Vice of Petra Scamborova Download |
Jan 7, 2022 | 32 | petitioner | IPR2021-00816, Petitioner's Updated Mandatory Notices Download |
Jan 18, 2022 | 33 | petitioner | IPR2021-00816, Petitioner's Updated Power of Attorney Download |
Jan 18, 2022 | 34 | petitioner | 2022-01-18, Petitioner's Updated Exhibit List Download |
Jan 18, 2022 | 36 | patent_own | Patent Owner's Contingent Motion to Amend Under 37 C.F.R. Section 42.121 [PUBLIC REDACTED VERSION] Download |
Jan 18, 2022 | 38 | patent_own | Patent Owners' Third Motion to Seal and Motion for a Modified Default Protective Order Download |
Jan 19, 2022 | 39 | patent_own | Patent Owner's Updated Exhibit List Download |
Jan 19, 2022 | 40 | patent_own | Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corporation's Patent Owner Response [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 41 | patent_own | Joint Stipulation to Modify Due Dates 1 and 2 Download |
Jan 25, 2022 | 42 | petitioner | IPR2021-00816, 2022-01-25, Updated Exhibit List Download |
Jan 26, 2022 | 43 | petitioner | Download |
Jan 26, 2022 | 44 | petitioner | IPR2021-00816, 2022-01-25, Motion for Pro Hac Vice - Robert Vlasis Download |
Jan 27, 2022 | 45 | board | ORDER Granting Petitioners Motion for Pro Hac Vice Admission of Robert Vlasis 37 C.F.R. sec 42.10 Download |
Feb 15, 2022 | 46 | petitioner | Petitioner's Updated Power of Attorney Download |
Feb 15, 2022 | 47 | petitioner | Petitioner's Updated Mandatory Notices Download |
Mar 2, 2022 | 48 | petitioner | IPR2021-00816 Deposition Notice of Kimberly Cameron Download |
Mar 2, 2022 | 49 | petitioner | IPR2021-00816 Deposition Notice of Juergen Sigg Download |
Mar 2, 2022 | 50 | petitioner | IPR2021-00816 Deposition Notice of Marie Picci Download |
Mar 2, 2022 | 51 | petitioner | IPR2021-00816 Deposition Notice of Karl Leinsing Download |
Mar 2, 2022 | 52 | petitioner | IPR2021-00816 Deposition Notice of Michael Miller Download |
Mar 2, 2022 | 53 | petitioner | Deposition Notice of Andrew F. Calman Download |
Mar 2, 2022 | 54 | petitioner | Deposition Notice of John Dillberger Download |
Mar 2, 2022 | 55 | petitioner | Deposition Notice of James Malackowski Download |
Mar 2, 2022 | 56 | petitioner | Deposition Notice of Jeremy Wolfe Download |
Mar 3, 2022 | 57 | board | Panel Change Order Download |
Mar 3, 2022 | 58 | patent_own | Patent Owner Novartis Pharma AG's Updated Power of Attorney Download |
Mar 3, 2022 | 59 | patent_own | Patent Owner Novartis Pharmaceuticals Corporation's Updated Power of Attorney Download |
Mar 3, 2022 | 60 | patent_own | Patent Owner Novartis Technology LLC's Updated Power of Attorney Download |
Mar 3, 2022 | 61 | patent_own | Patent Owners' Updated Mandatory Notices Download |
Mar 3, 2022 | 62 | patent_own | Joint Motion for the Appointment of Commissioners and Direction of Submission of Hague Convention Application Download |
Mar 3, 2022 | 63 | patent_own | Patent Owners' Updated Exhibit List Download |
Mar 7, 2022 | 64 | petitioner | 2022-03-07 - Petitioner's Updated Mandatory Notices Download |
Mar 8, 2022 | 65 | board | Order: Appointing Commissioners and Direction of Submission Download |
Mar 24, 2022 | 66 | patent_own | Download |
Mar 24, 2022 | 67 | patent_own | Patent Owners Updated Exhibit List Download |
Mar 30, 2022 | 68 | petitioner | Petitioner's Updated Mandatory Notices Pursuant to 37 C.F.R. 42.8 Download |
Apr 5, 2022 | 69 | board | Download |
Apr 8, 2022 | 70 | patent_own | Joint Stipulation to Modify Due Dates 2 and 3 Download |
Apr 15, 2022 | 71 | petitioner | Petitioner's Motion to Seal Download |
Apr 15, 2022 | 73 | petitioner | Petitioner's Reply to Patent Owner's Response Download |
Apr 15, 2022 | 75 | petitioner | Petitioner's Opposition to Patent Owner's Contingent Motion to Amend Download |
Apr 22, 2022 | 76 | patent_own | Patent Owners' Objections To Admissibility of Evidence Submitted by Petitioner Download |
May 3, 2022 | 77 | patent_own | Patent Owners' Notice of Deposition of James Agalloco Under 37 C.F.R. Section 42.53 Download |
May 3, 2022 | 78 | patent_own | Patent Owners' Notice of Deposition of Szilard Kiss Under 37 C.F.R. Section 42.53 Download |
May 4, 2022 | 79 | patent_own | Patent Owners' Notice of Deposition of Horst Koller Under 37 C.F.R. Section 42.53 Download |
May 4, 2022 | 80 | patent_own | Patent Owners' Notice of Deposition of Joel M. Cohen Under 37 C.F.R. Section 42.53 Download |
May 4, 2022 | 81 | patent_own | Patent Owners' Notice of Deposition of Kenneth S. Graham Under 37 C.F.R. Section 42.53 Download |
May 4, 2022 | 82 | patent_own | Patent Owners' Notice of Deposition of Lisa Cameron Under 37 C.F.R. Section 42.53 Download |
May 4, 2022 | 83 | patent_own | Patent Owners' Notice of Deposition of W. Gregory Sawyer Under 37 C.F.R. Section 42.53 Download |
May 6, 2022 | 84 | petitioner | Petitioner's Updated Exhibit List Download |
May 11, 2022 | 85 | patent_own | Patent Owners' Fourth Motion to Seal Download |
May 11, 2022 | 86 | patent_own | Patent Owners' Updated Exhibit List Download |
May 25, 2022 | 88 | board | Order: Other Download |
May 26, 2022 | 89 | patent_own | Patent Owner's Notice of Withdrawal of Its Contingent Motion to Amend Download |
May 26, 2022 | 90 | patent_own | Patent Owner's Fifth Motion to Seal Download |
May 26, 2022 | 91 | patent_own | Patent Owner's Updated Exhibit List Download |
May 26, 2022 | 93 | patent_own | Patent Owner's Surreply to Petitioner's Reply - REDACTED Download |
May 27, 2022 | 94 | patent_own | Notice of Certification of Word Count for Patent Owners' Surreply to Petitioner's Reply Download |
Jun 3, 2022 | 95 | petitioner | PETITIONER'S THIRD OBJECTIONS TO ADMISSIBILITY OF EVIDENCE SUBMITTED BY PATENT OWNER Download |
Jun 6, 2022 | 96 | petitioner | Download |
Jun 14, 2022 | 97 | petitioner | Petitioners Request For Oral Argument Download |
Jun 14, 2022 | 98 | patent_own | Patent Owner's Request for Oral Argument Download |
Jun 27, 2022 | 99 | board | Download |
Jun 30, 2022 | 100 | board | Preliminary Guidance Patent Owner's Motion to Amend (PUBLIC VERSION) Download |
Jul 5, 2022 | 101 | patent_own | Patent Owner's Motion to Exclude Evidence Download |
Jul 6, 2022 | 102 | patent_own | Joint Notice to Modify Date to Serve Demonstratives on Opposing Counsel Download |
Jul 8, 2022 | 103 | board | Order: Granting Patent Owner's Third, Fourth, and Fifth Motions to Seal - Granting Patent Owner's Motion for Entry of Second Modified Default Protective Order - 37 CFR 42.14 and 42.54 Download |
Jul 12, 2022 | 104 | petitioner | Petitioner's Opposition to Patent Owner's Motion to Exclude Download |
Jul 13, 2022 | 105 | board | Download |
Jul 13, 2022 | 106 | patent_own | Patent Owner's Second Updated Mandatory Notices Download |
Jul 13, 2022 | 107 | patent_own | Patent Owner's Updated Power of Attorney (Novartis Pharma AG) Download |
Jul 13, 2022 | 108 | patent_own | Patent Owner's Updated Power of Attorney (Novartis Pharmaceuticals Corporation) Download |
Jul 13, 2022 | 109 | patent_own | Patent Owner's Updated Power of Attorney (Novartis Technology Corporation) Download |
Jul 18, 2022 | 110 | patent_own | Download |
Aug 12, 2022 | 111 | petitioner | Joint Motion to Expunge Download |
Sep 6, 2022 | 112 | board | Other: Hearing transcript Download |
Oct 25, 2022 | 114 | board | Order: Dismissing Motion to Exclude as Moot 37 C.F.R. secs. 42.64c, 42.61a Download |
Nov 1, 2022 | 115 | board | Order: Directing the Submission of a Redacted Public Version of the Final Written Decision and Granting the Joint Motion to Expunge Certain Exhibits - 37 CFR 42.5 and 42.14 Download |
Dec 23, 2022 | 116 | patent_own | Patent Owner's Notice of Appeal Download |
Jan 20, 2023 | 117 | petitioner | Joint Motion to Seal the Final Written Decision Download |
Jan 24, 2023 | 119 | board | Final Written Decision: original Download |
Jan 24, 2023 | 120 | board | Order: Order: Granting Joint Motion to Seal Download |
Apr 16, 2021 | 1001 | petitioner | Download |
Apr 16, 2021 | 1002 | petitioner | Prosecution File History of U.S. Patent No. 9,220,631, part 3 Download |
Apr 16, 2021 | 1002 | petitioner | Prosecution File History of U.S. Patent No. 9,220,631, part 4 Download |
Apr 16, 2021 | 1002 | petitioner | Prosecution File History of U.S. Patent No. 9,220,631, part 1 Download |
Apr 16, 2021 | 1002 | petitioner | Prosecution File History of U.S. Patent No. 9,220,631, part 2 Download |
Apr 16, 2021 | 1003 | petitioner | Download |
Apr 16, 2021 | 1004 | petitioner | Curriculum Vitae of Horst Koller Download |
Apr 16, 2021 | 1005 | petitioner | Download |
Apr 16, 2021 | 1006 | petitioner | Download |
Apr 16, 2021 | 1007 | petitioner | Download |
Apr 16, 2021 | 1008 | petitioner | Download |
Apr 16, 2021 | 1009 | petitioner | Internet Archive WayBack Machine, March 7, 2011 Record of Drugs.com, Macugen Prescribing Information Download |
Apr 16, 2021 | 1010 | petitioner | ITC Investigation No. 337-TA-1207, Initial Determination Terminating the Investigation Download |
Apr 16, 2021 | 1011 | petitioner | Download |
Apr 16, 2021 | 1012 | petitioner | Download |
Apr 16, 2021 | 1013 | petitioner | Download |
Apr 16, 2021 | 1014 | petitioner | Download |
Apr 16, 2021 | 1015 | petitioner | Download |
Apr 16, 2021 | 1015 | petitioner | Download |
Apr 16, 2021 | 1015 | petitioner | Download |
Apr 16, 2021 | 1015 | petitioner | Download |
Apr 16, 2021 | 1016 | petitioner | Download |
Apr 16, 2021 | 1016 | petitioner | Download |
Apr 16, 2021 | 1016 | petitioner | Download |
Apr 16, 2021 | 1016 | petitioner | Download |
Apr 16, 2021 | 1017 | petitioner | Download |
Apr 16, 2021 | 1018 | petitioner | Download |
Apr 16, 2021 | 1019 | petitioner | U.S. Pharmacopeia, USP 789, Particulate Matter in Ophthalmic Solutions, USP 34 NF 29 (2011) Download |
Apr 16, 2021 | 1020 | petitioner | Download |
Apr 16, 2021 | 1021 | petitioner | Download |
Apr 16, 2021 | 1022 | petitioner | Download |
Apr 16, 2021 | 1023 | petitioner | Download |
Apr 16, 2021 | 1024 | petitioner | Download |
Apr 16, 2021 | 1025 | petitioner | Download |
Apr 16, 2021 | 1026 | petitioner | Download |
Apr 16, 2021 | 1027 | petitioner | Download |
Apr 16, 2021 | 1028 | petitioner | Download |
Apr 16, 2021 | 1029 | petitioner | Download |
Apr 16, 2021 | 1030 | petitioner | Download |
Apr 16, 2021 | 1031 | petitioner | Download |
Apr 16, 2021 | 1032 | petitioner | Curriculum Vitae of Dr. Szilard Kiss Download |
Apr 16, 2021 | 1033 | petitioner | Declaration of James L. Mullins, Ph.D. Download |
Apr 16, 2021 | 1034 | petitioner | Download |
Apr 16, 2021 | 1035 | petitioner | European Patent Application No. 12174860 to Novartis AG Download |
Apr 16, 2021 | 1036 | petitioner | Download |
Apr 16, 2021 | 1037 | petitioner | Affidavit of Internet Archive Office Manager Download |
Apr 16, 2021 | 1038 | petitioner | Internet Archive WayBack Machine, March 8, 2011 Record of Drugs.com, Welcome to Drugs.com Download |
Apr 16, 2021 | 1039 | petitioner | Internet Archive WayBack Machine, February 25, 2011 Record of Drugs.com, FDA Professional Drug Information Download |
Apr 16, 2021 | 1040 | petitioner | Download |
Apr 16, 2021 | 1041 | petitioner | Download |
Apr 16, 2021 | 1042 | petitioner | Download |
Apr 16, 2021 | 1043 | petitioner | Download |
Apr 16, 2021 | 1044 | petitioner | Download |
Apr 16, 2021 | 1045 | petitioner | Download |
Apr 16, 2021 | 1046 | petitioner | Download |
Apr 16, 2021 | 1047 | petitioner | Download |
Apr 16, 2021 | 1048 | petitioner | Download |
Apr 16, 2021 | 1049 | petitioner | Download |
Apr 16, 2021 | 1050 | petitioner | Download |
Apr 16, 2021 | 1051 | petitioner | Download |
Apr 16, 2021 | 1052 | petitioner | Download |
Apr 16, 2021 | 1053 | petitioner | FDA Pesticide Analytical Manual Vol. 1, Chapter 6 - HPLC Download |
Apr 16, 2021 | 1054 | petitioner | Download |
Apr 16, 2021 | 1055 | petitioner | Download |
Apr 16, 2021 | 1056 | petitioner | Download |
Apr 16, 2021 | 1057 | petitioner | Download |
Apr 16, 2021 | 1058 | petitioner | Christine I. Falkner-Radler, et al. Needle Size in Intravitreal Injections-Preliminary Results of a Randomized Clinical Trial, AVRO Annual Meeting Abstract, March 2012, 54(884) Download |
Apr 16, 2021 | 1059 | petitioner | Download |
Apr 16, 2021 | 1060 | petitioner | Curriculum Vitae of James L. Mullins, Ph.D. Download |
Apr 16, 2021 | 1061 | petitioner | Download |
Apr 16, 2021 | 1062 | petitioner | Download |
Apr 16, 2021 | 1063 | petitioner | Evangelos S. Gragoudas, et al. Pegaptanib for Neovascular Age-Related Macular Degeneration, New England Journal of Medicine 2004; 351:2805-16, with Supplementary Appendix. Download |
Apr 16, 2021 | 1064 | petitioner | IPR2020-1317, Paper No. 15, Institution Decision Download |
Apr 16, 2021 | 1065 | petitioner | Anita M. Leys, et al. Neovascular Growth Following Photodynamic Therapy for Choroidal Hemangioma and Neovascular Regression after Intravitreous Injection of Triamcinolone, Retina 2006; 26(6):693-7 Download |
Apr 16, 2021 | 1066 | petitioner | Australian Government, Department of Health and Ageing, Australian Public Assessment Report for Aflibercept, (July 2012), part 1 Download |
Apr 16, 2021 | 1066 | petitioner | Australian Government, Department of Health and Ageing, Australian Public Assessment Report for Aflibercept, (July 2012), part 2 Download |
Apr 16, 2021 | 1067 | petitioner | Sophie J. Bakri and Noha S. Ekdawi, Intravitreal Silicone Oil Droplets after Intravitreal Drug Injections, Retina 2008; 20:996-1001 Download |
Apr 16, 2021 | 1068 | petitioner | Jared S. Bee, et al. Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals, Journal of Pharmaceutical Science (Oct. 2011) Download |
Apr 16, 2021 | 1069 | petitioner | Michael Colucciello, Prefilled Syringe Delivery of Intravitreal Anti-VEGF Medications: Advantages for Patients and Physicians, Retinal Physician (Mar. 1, 2019) Download |
Apr 16, 2021 | 1070 | petitioner | Download |
Apr 16, 2021 | 1071 | petitioner | Department of Health & Human Services, Macugen Approval Letter (Dec. 18, 2004) Download |
Apr 16, 2021 | 1072 | petitioner | Lonny Wolgemuth, Challenges with Prefilled Syringes: The Parylene Solution, ONdrugDelivery (Oct. 2012) Download |
Apr 16, 2021 | 1073 | petitioner | Therese M. Sassalos, Prefilled Syringes for Intravitreal Drug Delivery, Clinical Ophthalmology 2019:13 701-706 Download |
Apr 16, 2021 | 1074 | petitioner | SCS Coating Systems, SCS Parylene Properties (2007) Download |
Apr 16, 2021 | 1075 | petitioner | Lonny Wolgemuth, Assessing the Effects of Sterilization Methods on Parylene Coating, Medical Device & Diagnostic Industry, (Aug. 2002) Download |
Apr 16, 2021 | 1076 | petitioner | Download |
Apr 16, 2021 | 1077 | petitioner | SDNY 20-5502 Docket Download |
Apr 16, 2021 | 1078 | petitioner | Federal Court Statistics Download |
Apr 16, 2021 | 1079 | petitioner | Novartis Letter to NDNY Court Download |
Apr 16, 2021 | 1080 | petitioner | Mehmet S. Kocabora, et al. Intravitreal Silicone Oil Droplets Following Pegaptanib Injection, Acta Ophthalmologica 2010 Download |
Apr 16, 2021 | 1081 | petitioner | Macugen Label (2008) Download |
Apr 16, 2021 | 1082 | petitioner | U.S. Pharmacopeia, USP 789, Particulate Matter in Ophthalmic Solutions, USP 32 NF 27 (2009) Download |
Apr 16, 2021 | 1083 | petitioner | Novartis NDNY Complaint Download |
Apr 16, 2021 | 1084 | petitioner | Novartis Letter to SDNY Court Download |
Apr 16, 2021 | 1085 | petitioner | ITC Investigation No. 337-TA-1207, Statement on the Public Interest by Proposed Respondent Regeneron Pharmaceuticals, Inc. Download |
Apr 16, 2021 | 1086 | petitioner | ITC Investigation No. 337-TA-1207, Statement on the Public Interest by Szilard Kiss Download |
Apr 16, 2021 | 1087 | petitioner | Download |
Apr 16, 2021 | 1088 | petitioner | PCT Patent Publication No. WO 2007/084765 to Deschatelets et al. Download |
Apr 16, 2021 | 1089 | petitioner | PCT Patent Publication No. WO 97/44068 to Tack et al. Download |
Aug 20, 2021 | 1090 | petitioner | Text Minute Entry re Rule 16 Conference held on August 18, 2021, Novartis Pharma AG et al v. Regeneron Pharma., Inc., No. 1:20-cv-00690 (N.D.N.Y. Aug. 18, 2021) Download |
Nov 23, 2021 | 1091 | petitioner | Declaration of Juergen Sigg Download |
Nov 23, 2021 | 1092 | petitioner | Download |
Nov 23, 2021 | 1093 | petitioner | Download |
Nov 23, 2021 | 1094 | petitioner | ONDrugDelivery, Prefilled Syringe, available at https://ondrugdelivery.com/magazines/prefilled-syringes-the-rise-of-the-delivery-device-portfolio/ Download |
Dec 22, 2021 | 1095 | petitioner | Declaration of Petra Scamborova Download |
Dec 22, 2021 | 1096 | petitioner | P. Scamborova LinkedIn Profile Download |
Jan 18, 2022 | 1097 | petitioner | Ex. 1097, 2022-01-06 Telephonic Conference Download |
Jan 25, 2022 | 1098 | petitioner | Ex. 1098, Declaration of Robert T. Vlasis ISO Motion for Pro Hac Vice Download |
Jan 25, 2022 | 1099 | petitioner | Ex. 1099, Bio for Robert T. Vlasis - Weil Gotshal Manges Download |
Apr 15, 2022 | 1100 | petitioner | Declaration of James Agalloco Download |
Apr 15, 2022 | 1101 | petitioner | Declaration of Dr. Gregory Sawyer Download |
Apr 15, 2022 | 1102 | petitioner | Declaration of Dr. Kenneth Graham Download |
Apr 15, 2022 | 1103 | petitioner | Second Declaration of James L. Mullins, Ph.D. Download |
Apr 15, 2022 | 1105 | petitioner | Reply Declaration of Horst Koller Download |
Apr 15, 2022 | 1106 | petitioner | Reply Declaration of Dr. Szilard Kiss Download |
Apr 15, 2022 | 1107 | petitioner | Declaration of Lisa Cameron Download |
Apr 15, 2022 | 1108 | petitioner | Declaration of Joel M. Cohen Download |
Apr 15, 2022 | 1109 | petitioner | Deposition of Kim Cameron, Ph.D., (3/17/2022) Download |
Apr 15, 2022 | 1110 | petitioner | Persson, et. al., Elastic contact mechanics: Percolation of the contact area and fluid squeeze-out, Eur. Phys. J. E. (2012) Download |
Apr 15, 2022 | 1111 | petitioner | Nishimoto, et al., Determination of Conditions for the Production Scale Sterilization of Prefilled Syringes, 57 PDA J Pharm Sci. & Tech, 378-386 (2003) Download |
Apr 15, 2022 | 1115 | petitioner | Download |
Apr 15, 2022 | 1129 | petitioner | Download |
Apr 15, 2022 | 1163 | petitioner | REGITC00138524 - Requirements on pre-fillable glass syringes Download |
Apr 15, 2022 | 1164 | petitioner | Optical in Situ Micro Tribometer for Analysis of Real Contact Area for Contact Mechanics, Adhesion, and Sliding Experiments, B. A. Krick, J. R. Vail, B. N. J. Persson, and W. G. Sawyer, Tribology Letters 45 (2012) 185-194 Download |
Apr 15, 2022 | 1165 | petitioner | Plasmonic Diagnostics for Tribology: In Situ Observations using Surface Plasmon Resonance in Combination with Surface-Enhanced Raman Spectroscopy, B. A. Krick, D. H. Hahn, and W. G. Sawyer, Tribology Letters, 49 (2013) 95-102. Download |
Apr 15, 2022 | 1166 | petitioner | Accessing Inaccessible Interfaces: In Situ Approaches to Materials Tribology, W. G. Sawyer & K. J. Wahl, Guest Editors MRS Bulletin 33 (2008) 1145-1189 Download |
Apr 15, 2022 | 1169 | petitioner | Lorenz, et al., Static or breakloose friction for lubricated contacts: the role of surface roughness and dewetting, J. Phys. Condens. Matter 25 (2013) Download |
Apr 15, 2022 | 1170 | petitioner | Curriculum Vitae of Lisa Cameron Download |
Apr 15, 2022 | 1171 | petitioner | Download |
Apr 15, 2022 | 1172 | petitioner | Deposition of James E. Malackowski, IPR2021-00816 (3/29/2022) Download |
Apr 15, 2022 | 1173 | petitioner | Jesse David and Marion Stewart, Commercial Success: Economic Principles Applied to Patent Litigation Download |
Apr 15, 2022 | 1174 | petitioner | Download |
Apr 15, 2022 | 1175 | petitioner | Download |
Apr 15, 2022 | 1176 | petitioner | Download |
Apr 15, 2022 | 1177 | petitioner | Download |
Apr 15, 2022 | 1178 | petitioner | Novartis Ophthalmics and Genentech announce development and commercialization agreement for age-related macular degeneration treatment, Lucentis(TM), Novartis Pharma AG press release, June 25, 2003 Download |
Apr 15, 2022 | 1179 | petitioner | Bayer HealthCare AG And Regeneron Pharmaceuticals, Inc. To Collaborate On VEGF Trap For The Treatment Of Eye Diseases Regeneron Retains U.S. Commercialization Rights, Receives $75 Million Upfront, October 19, 2006 Download |
Apr 15, 2022 | 1180 | petitioner | Download |
Apr 15, 2022 | 1181 | petitioner | Beovu (brolucizumab injection) now publicly reimbursed in Ontario and New Brunswick for the treatment of neovascular (wet) age-related macular degeneration, Yahoo Finance, December 16, 2021 Download |
Apr 15, 2022 | 1182 | petitioner | Mali Okada et al., Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration: A Mixed Methods Systematic Review,
Ophthalmology 128(2):234-247, August 5, 2020 Download |
Apr 15, 2022 | 1183 | petitioner | Download |
Apr 15, 2022 | 1184 | petitioner | Turbert, What is Avastin?, American Academy of Ophthalmology, April 23, 2021 Download |
Apr 15, 2022 | 1186 | petitioner | Highlights of Prescribing Information, Avastin, FDA, revised December 2020 Download |
Apr 15, 2022 | 1187 | petitioner | Callan Navitsky, The Regulation of Compounding Pharmacies, Retina Today, November/December 2012 Download |
Apr 15, 2022 | 1188 | petitioner | Highlights of Prescribing Information, Beovu, revised March, 2022 Download |
Apr 15, 2022 | 1189 | petitioner | Download |
Apr 15, 2022 | 1190 | petitioner | Angus Liu, Novartis calls off 3 Beovu trials testing more frequent dosing on concerns of vision-threatening side effect, FiercePharma, June 1, 2021 Download |
Apr 15, 2022 | 1191 | petitioner | Highlights of Prescribing Information, Macugen, revised July 2011 Download |
Apr 15, 2022 | 1192 | petitioner | Highlights of Prescribing Information, Susvimo, revised October 2021, Download |
Apr 15, 2022 | 1193 | petitioner | Susvimo 10 Mg/0.1Ml Implant Solution Macular Degeneration Treatment Agents-VEGF Antagonist Type- Uses, Side Effects, and More, WebMD Download |
Apr 15, 2022 | 1194 | petitioner | Download |
Apr 15, 2022 | 1195 | petitioner | Download |
Apr 15, 2022 | 1196 | petitioner | Highlights of Prescribing Information, Vabysmo, revised January 2022, Download |
Apr 15, 2022 | 1197 | petitioner | Jarosz and Vigil International In-house Counsel Journal Summer 2015 Assessing Commercial Success at the U.S. Patent Trial and Appeal Board Download |
Apr 15, 2022 | 1198 | petitioner | Download |
Apr 15, 2022 | 1199 | petitioner | Excerpt of Wooldridge, Jeffrey M., Econometric Analysis of Cross Section and Panel Data, MIT Press Download |
Apr 15, 2022 | 1200 | petitioner | Highlights of Prescribing Information, Lucentis, FDA, revised October 2016 Download |
Apr 15, 2022 | 1201 | petitioner | Highlights of Prescribing Information, Lucentis, FDA, revised January 2017 Download |
Apr 15, 2022 | 1202 | petitioner | Highlights of Prescribing Information, Lucentis, FDA, revised August 2012 Download |
Apr 15, 2022 | 1204 | petitioner | Our Services, Vetter, accessed February 24, 2022 Download |
Apr 15, 2022 | 1208 | petitioner | Deposition of Andrew F. Calman, IPR2021-00816 Download |
Apr 15, 2022 | 1209 | petitioner | Deposition of John Dillberger, IPR2021-00816 Download |
Apr 15, 2022 | 1210 | petitioner | Deposition of Michael J. Miller, IPR2021-00816 Download |
Apr 15, 2022 | 1212 | petitioner | Deposition of Jeremy Wolfe, IPR2021-00816 (3/19/2022) Download |
Apr 15, 2022 | 1214 | petitioner | Kinney, Delivering Therapeutic siRNA, Drug Delivery Technology, Vol. 9, No. 2 (Feb. 2009) Download |
Apr 15, 2022 | 1227 | petitioner | REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (3/6) Download |
Apr 15, 2022 | 1227 | petitioner | REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (1/6) Download |
Apr 15, 2022 | 1227 | petitioner | REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (6/6) Download |
Apr 15, 2022 | 1227 | petitioner | REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (4/6) Download |
Apr 15, 2022 | 1227 | petitioner | REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (5/6) Download |
Apr 15, 2022 | 1227 | petitioner | REG_NDNY_00000004 - Gilead Sciences Inc. Form 10-K (2/6) Download |
Apr 15, 2022 | 1229 | petitioner | Lambert, Rationale for practical medical device accelerated
aging programs in AAMI TIR 17, Radiation Physics and
Chemistry, 57 (2000) 349-353 Download |
Apr 15, 2022 | 1230 | petitioner | Standard Guide for Accelerated Aging of Sterile Medical Device
Packages, Designation: F-1980-02 Download |
Apr 15, 2022 | 1231 | petitioner | Center for Drug Evaluation and Research, Application No. NDA
22-220, Trivaris Download |
Apr 15, 2022 | 1232 | petitioner | Internet Archive WayBack Machine, Eyetech, Inc.: Science, Vision, Hope Download |
Apr 15, 2022 | 1233 | petitioner | Download |
Apr 15, 2022 | 1234 | petitioner | Download |
Apr 15, 2022 | 1235 | petitioner | Download |
Apr 15, 2022 | 1236 | petitioner | Download |
Apr 15, 2022 | 1237 | petitioner | Download |
Apr 15, 2022 | 1238 | petitioner | Download |
Apr 15, 2022 | 1239 | petitioner | Download |
Apr 15, 2022 | 1240 | petitioner | Download |
Apr 15, 2022 | 1241 | petitioner | Download |
Apr 15, 2022 | 1242 | petitioner | R. DeForest McDuff, Ryan C. Andrews, and Matt D. Brundage, Thinking Economically about Commercial Success, Landslide, 9(4): 1-5 (Mar./Apr. 2017) Download |
Apr 15, 2022 | 1243 | petitioner | Kevin L. Varghese, No Need to Neglect Nexus: Prosecution Lessons from FOX Factory v. SRAM, Intellectual Property & Tech. Law J., 32(6): 16 (June 2020) Download |
Apr 15, 2022 | 1244 | petitioner | Ernst R. Berndt et al., Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market, The American Economic Review 85(2): 102-103 (1995) Download |
Apr 15, 2022 | 1245 | petitioner | Excerpt of Opening Report of Szilard Kiss, M.D., ITC Inv. No. 337-TA-1207 (Jan. 22, 2021) Download |
Apr 15, 2022 | 1246 | petitioner | GlobalData Healthcare, The dominance of Eylea is expected to persist in the foreseeable future, Pharma Tech., July 1, 2020 (updated Dec. 1, 2021) Download |
Apr 15, 2022 | 1247 | petitioner | Helen Marshall, Eylea (aflibercept), Medical News Today, February 16, 2020 Download |
Apr 15, 2022 | 1250 | petitioner | REGITC00376214 - Novartis Completes Safety Review and Initiates Update to the Beovu Information Worldwide Download |
Apr 15, 2022 | 1251 | petitioner | Download |
Apr 15, 2022 | 1252 | petitioner | Application No. 13382380 File History Excerpts Download |
Apr 15, 2022 | 1253 | petitioner | Download |
Jan 20, 2023 | 1257 | petitioner | Redacted Final Written Decision Download |
Jul 28, 2021 | 2001 | patent_own | Declaration of Karl R. Leinsing, PE Download |
Jul 28, 2021 | 2002 | patent_own | Declaration of Marie Picci [Public Redacted Version] Download |
Jul 28, 2021 | 2003 | patent_own | 2003 Download |
Jul 28, 2021 | 2004 | patent_own | 2004 Download |
Jul 28, 2021 | 2005 | patent_own | 2005 Download |
Jul 28, 2021 | 2006 | patent_own | 2006 Download |
Jul 28, 2021 | 2007 | patent_own | 2007 Download |
Jul 28, 2021 | 2008 | patent_own | 2008 Download |
Jul 28, 2021 | 2009 | patent_own | 2009 Download |
Jul 28, 2021 | 2010 | patent_own | 2010 Download |
Jul 28, 2021 | 2011 | patent_own | 2011 Download |
Jul 28, 2021 | 2012 | patent_own | 2012 Download |
Jul 28, 2021 | 2013 | patent_own | 2013 Download |
Jul 28, 2021 | 2014 | patent_own | 2014 Download |
Jul 28, 2021 | 2015 | patent_own | 2015 Download |
Jul 28, 2021 | 2016 | patent_own | 2016 Download |
Jul 28, 2021 | 2017 | patent_own | 2017 Download |
Jul 28, 2021 | 2018 | patent_own | 2018 Download |
Jul 28, 2021 | 2019 | patent_own | 2019 Download |
Jul 28, 2021 | 2020 | patent_own | 2020 Download |
Jul 28, 2021 | 2021 | patent_own | 2021 Download |
Jul 28, 2021 | 2022 | patent_own | 2022 Download |
Jul 28, 2021 | 2023 | patent_own | 2023 Download |
Jul 28, 2021 | 2024 | patent_own | 2024 Download |
Jul 28, 2021 | 2025 | patent_own | 2025 Download |
Jul 28, 2021 | 2026 | patent_own | 2026 Download |
Jul 28, 2021 | 2027 | patent_own | 2027 Download |
Jul 28, 2021 | 2028 | patent_own | 2028 Download |
Jul 28, 2021 | 2029 | patent_own | 2029 Download |
Jul 28, 2021 | 2030 | patent_own | 2030 Download |
Jul 28, 2021 | 2031 | patent_own | 2031 Download |
Jul 28, 2021 | 2032 | patent_own | 2032 Download |
Jul 28, 2021 | 2033 | patent_own | 2033 Download |
Jul 28, 2021 | 2034 | patent_own | 2034 Download |
Jul 28, 2021 | 2035 | patent_own | 2035 Download |
Jul 28, 2021 | 2036 | patent_own | 2036 Download |
Jul 28, 2021 | 2041 | patent_own | 2041 Download |
Jul 28, 2021 | 2042 | patent_own | 2042 Download |
Jul 28, 2021 | 2044 | patent_own | 2044 Download |
Jul 28, 2021 | 2045 | patent_own | 2045 Download |
Jul 28, 2021 | 2046 | patent_own | 2046 Download |
Jul 28, 2021 | 2047 | patent_own | 2047 Download |
Jul 28, 2021 | 2048 | patent_own | 2048 Download |
Jul 28, 2021 | 2049 | patent_own | 2049 Download |
Jul 28, 2021 | 2050 | patent_own | 2050 Download |
Jul 28, 2021 | 2051 | patent_own | 2051 Download |
Jul 28, 2021 | 2052 | patent_own | 2052 Download |
Jul 28, 2021 | 2053 | patent_own | 2053 Download |
Jul 28, 2021 | 2054 | patent_own | 2054 Download |
Jul 28, 2021 | 2055 | patent_own | 2055 Download |
Jul 28, 2021 | 2056 | patent_own | 2056 Download |
Jul 28, 2021 | 2057 | patent_own | 2057 Download |
Jul 28, 2021 | 2058 | patent_own | 2058 Download |
Jul 28, 2021 | 2059 | patent_own | 2059 Download |
Jul 28, 2021 | 2060 | patent_own | 2060 Download |
Jul 28, 2021 | 2061 | patent_own | 2061 Download |
Jul 28, 2021 | 2062 | patent_own | Declaration of Jeffrey Salling Download |
Jan 18, 2022 | 2062 | patent_own | Ex. 2062 - Jeffrey Salling Declaration Download |
Nov 19, 2021 | 2063 | patent_own | Exhibit 2063 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2064 | patent_own | Exhibit 2064 [PUBLIC REDACTED VERSION] Download |
Jul 28, 2021 | 2065 | patent_own | 2065 Download |
Nov 19, 2021 | 2066 | patent_own | Exhibit 2066 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2067 | patent_own | Exhibit 2067 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2068 | patent_own | Exhibit 2068 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2069 | patent_own | Exhibit 2069 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2070 | patent_own | Exhibit 2070 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2071 | patent_own | Exhibit 2071 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2072 | patent_own | Exhibit 2072 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2073 | patent_own | Exhibit 2073 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2074 | patent_own | Exhibit 2074 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2075 | patent_own | Exhibit 2075 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2076 | patent_own | Exhibit 2076 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2077 | patent_own | Exhibit 2077 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2078 | patent_own | Exhibit 2078 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2079 | patent_own | Exhibit 2079 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2080 | patent_own | Exhibit 2080 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2081 | patent_own | Exhibit 2081 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2082 | patent_own | Exhibit 2082 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2083 | patent_own | Exhibit 2083 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2084 | patent_own | Exhibit 2084 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2085 | patent_own | Exhibit 2085 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2086 | patent_own | Exhibit 2086 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2087 | patent_own | Exhibit 2087 [PUBLIC REDACTED VERSION] Download |
Nov 19, 2021 | 2088 | patent_own | Exhibit 2088 [PUBLIC REDACTED VERSION] Download |
Jul 28, 2021 | 2089 | patent_own | 2089 Download |
Jul 28, 2021 | 2090 | patent_own | 2090 Download |
Jul 28, 2021 | 2091 | patent_own | 2091 Download |
Jul 28, 2021 | 2092 | patent_own | 2092 Download |
Aug 27, 2021 | 2093 | patent_own | Exhibit 2093 Download |
Aug 27, 2021 | 2094 | patent_own | Exhibit 2094 Download |
Aug 27, 2021 | 2095 | patent_own | Exhibit 2095 Download |
Aug 27, 2021 | 2096 | patent_own | Exhibit 2096 Download |
Nov 19, 2021 | 2097 | patent_own | Download |
Dec 22, 2021 | 2098 | patent_own | Exhibit 2098 - Declaration of Nicholas K. Mitrokostas in Support of Patent Owners Motion for Pro Hac Vice Admission of Nicholas K. Mitrokostas Under 37 C.F.R. Section 42.10(c) Download |
Jan 18, 2022 | 2116 | patent_own | Ex. 2116 - Genentech Press Release Download |
Jan 18, 2022 | 2117 | patent_own | Ex. 2117 - Genentech Press Release Download |
Jan 19, 2022 | 2118 | patent_own | Ex. 2118 - NOVITC(CH)00002720 [Public Redacted Version] Download |
Jan 19, 2022 | 2119 | patent_own | Ex. 2119 - NOVITC(CH)00003455 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2120 | patent_own | Ex. 2120 - NOVITC(CH)00004818 [Public Redacted Version - Replacement] Download |
Jan 19, 2022 | 2121 | patent_own | Ex. 2121 - NOVITC(CH)00005765 [Public Redacted Version] Download |
Jan 19, 2022 | 2123 | patent_own | Ex. 2123 - NOVITC(CH)00007283 [Public Redacted Version] Download |
Jan 19, 2022 | 2124 | patent_own | Ex. 2124 - NOVITC(CH)00008409 [Public Redacted Version] Download |
Jan 18, 2022 | 2125 | patent_own | Ex. 2125 - Lucentis Prescribing Information Download |
Jan 19, 2022 | 2125 | patent_own | Ex. 2125 - Lucentis Prescribing Information, revised March 2018 Download |
Jan 18, 2022 | 2125 | patent_own | Ex. 2125 - Lucentis Prescribing Information, revised March 2018 Download |
Jan 19, 2022 | 2126 | patent_own | Ex. 2126 - NOVITC(CH)00054063 [Public Redacted Version] Download |
Jan 19, 2022 | 2128 | patent_own | Ex. 2128 - NOVITC(CH)00167663 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2129 | patent_own | Ex. 2129 - NOVITC(CH)00168961 [Public Redacted Version] Download |
Jan 19, 2022 | 2130 | patent_own | Ex. 2130 - NOVITC(CH)00169036 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2131 | patent_own | Ex. 2131 - NOVITC(CH)00170304 [Public Redacted Version] Download |
Jan 19, 2022 | 2133 | patent_own | Ex. 2133 - NOVITC(CH)00170896 [Public Redacted Version] Download |
Jan 19, 2022 | 2134 | patent_own | Ex. 2134 - NOVITC(CH)00170915 [Public Redacted Version] Download |
Jan 19, 2022 | 2136 | patent_own | Ex. 2136 - NOVITC(CH)00217349 [Public Redacted Version] Download |
Jan 19, 2022 | 2137 | patent_own | Ex. 2137 - NOVITC(CH)00217646 [Public Redacted Version] Download |
Jan 19, 2022 | 2138 | patent_own | Ex. 2138 - NOVITC(CH)00217650 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2139 | patent_own | Ex. 2139 - NOVITC(CH)00810847 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2140 | patent_own | Ex. 2140 - NOVITC(CH)00874056 [Public Redacted Version] Download |
Jan 19, 2022 | 2141 | patent_own | Ex. 2141 - NOVITC(CH)00880433 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2142 | patent_own | Ex. 2142 - NOVITC(CH)01494800 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2143 | patent_own | Ex. 2143 - NOVITC(CH)01495912 [Public Redacted Version] Download |
Jan 19, 2022 | 2144 | patent_own | Ex. 2144 - NOVITC(CH)01498292 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2145 | patent_own | Ex. 2145 - NOVITC(CH)01863737 [Public Redacted Version] Download |
Jan 19, 2022 | 2146 | patent_own | Ex. 2146 - NOVITC(CH)01863785 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2147 | patent_own | Ex. 2147 - NOVITC(CH)01906307 [PUBLIC REDACTED VERSION] Download |
Jan 19, 2022 | 2148 | patent_own | Ex. 2148 - NOVITC(CH)02022271 [Public Redacted Version] Download |
Jan 19, 2022 | 2150 | patent_own | Ex. 2150 - NOVITC(CH)02929814 [Public Redacted Version] Download |
Jan 19, 2022 | 2152 | patent_own | Ex. 2152 - NOVITC(US)00000788 [Public Redacted Version] Download |
Jan 19, 2022 | 2153 | patent_own | Ex. 2153 - NOVITC(US)00000792 [Public Redacted Version] Download |
Jan 19, 2022 | 2154 | patent_own | Ex. 2154 - NOVITC(US)00000795 [Public Redacted Version] Download |
Jan 19, 2022 | 2155 | patent_own | Ex. 2155 - NOVITC(US)00006151 [Public Redacted Version] Download |
Jan 19, 2022 | 2156 | patent_own | Ex. 2156 - NOVITC(US)00006173 [Public Redacted Version] Download |
Jan 19, 2022 | 2157 | patent_own | Ex. 2157 - NOVITC(US)00006182 [Public Redacted Version] Download |
Jan 19, 2022 | 2158 | patent_own | Ex. 2158 - NOVITC(US)00006196 [Public Redacted Version] Download |
Jan 19, 2022 | 2159 | patent_own | Ex. 2159 - NOVITC(US)00006213 [Public Redacted Version] Download |
Jan 18, 2022 | 2160 | patent_own | Ex. 2160 - Lucentis PFS Letter and Label Download |
Jan 18, 2022 | 2161 | patent_own | Ex. 2161 - Roche Finance Report for 2016 Download |
Jan 19, 2022 | 2161 | patent_own | Ex. 2161 - Roche Finance Report for 2016 Download |
Jan 18, 2022 | 2162 | patent_own | Ex. 2162 - Roche Finance Report for 2014 Download |
Jan 19, 2022 | 2162 | patent_own | Ex. 2162 - Roche Finance Report for 2014 Download |
Jan 18, 2022 | 2163 | patent_own | Ex. 2163 - Roche Finance Report for 2019 Download |
Jan 19, 2022 | 2163 | patent_own | Ex. 2163 - Roche Finance Report for 2019 Download |
Jan 19, 2022 | 2164 | patent_own | Exhibit 2164 - Roche Finance Report 2013 Part 2 of 2 Download |
Jan 19, 2022 | 2164 | patent_own | Ex. 2164 - Roche Finance Report 2013 Part 1 of 2 Download |
Jan 19, 2022 | 2166 | patent_own | Ex. 2166 - NOVITC(US)00389194 [Public Redacted Version] Download |
Jan 19, 2022 | 2167 | patent_own | Ex.. 2167 - NOVITC(US)00394737 [Public Redacted Version] Download |
Jan 19, 2022 | 2168 | patent_own | Ex. 2168 - NOVITC(US)00395564 [Public Redacted Version] Download |
Jan 19, 2022 | 2169 | patent_own | Ex. 2169 - NOVITC(US)00395565 [Public Redacted Version] Download |
Jan 19, 2022 | 2170 | patent_own | Ex. 2170 - NOVITC(US)00507243 [Public Redacted Version] Download |
Jan 19, 2022 | 2171 | patent_own | Ex. 2171 - NOVITC(US)00697489 [Public Redacted Version] Download |
Jan 19, 2022 | 2172 | patent_own | Ex. 2172 - NOVITC(US)00718202 [Public Redacted Version] Download |
Jan 18, 2022 | 2174 | patent_own | Ex. 2174 - WHO Guidelines on Packaging for Pharmaceutical Products Download |
Jan 18, 2022 | 2175 | patent_own | Ex. 2175 - Akers 2010 Download |
Jan 18, 2022 | 2176 | patent_own | Ex. 2176 - Boven 2005 Download |
Jan 18, 2022 | 2177 | patent_own | Ex. 2177 - Tzannis 1996 Download |
Jan 18, 2022 | 2178 | patent_own | Ex. 2178 - Markovic 2009 Download |
Jan 18, 2022 | 2179 | patent_own | Ex. 2179 - Markovic 2011 Download |
Jan 18, 2022 | 2180 | patent_own | Ex. 2180 - Silver 2008 Download |
Jan 18, 2022 | 2181 | patent_own | Ex. 2181 - ISO-10993-1-2009 Download |
Jan 18, 2022 | 2182 | patent_own | Ex. 2182 - Helmus 2008 Download |
Jan 18, 2022 | 2183 | patent_own | Ex. 2183 - FDA Use of ISO-10993 Download |
Jan 18, 2022 | 2184 | patent_own | Ex. 2184 - Rathore 2008 Download |
Jan 19, 2022 | 2185 | patent_own | Ex. 2185 - Ansel 1995 Download |
Jan 19, 2022 | 2186 | patent_own | Ex. 2186 - Lachman 1986 Download |
Jan 19, 2022 | 2187 | patent_own | Ex. 2187 - ANSIAAMI ST67-2011 Download |
Jan 19, 2022 | 2188 | patent_own | Ex. 2188 - ISO 14161 Download |
Jan 18, 2022 | 2189 | patent_own | Ex. 2189 - Koller IPR Dep. Tr. Part 2 of 2 Download |
Jan 18, 2022 | 2189 | patent_own | Ex. 2189 - Koller IPR Dep. Tr. Part 1 of 2 Download |
Jan 19, 2022 | 2190 | patent_own | Ex. 2190 - Bash and Gould 1984 Download |
Jan 19, 2022 | 2191 | patent_own | Ex. 2191 - CFR 2004 Download |
Jan 19, 2022 | 2192 | patent_own | Ex. 2192 - CFR 2008 Download |
Jan 19, 2022 | 2193 | patent_own | Ex. 2193 - CFR 2021 Download |
Jan 19, 2022 | 2195 | patent_own | Ex. 2195 - Poche 2019 Download |
Jan 19, 2022 | 2196 | patent_own | Ex. 2196 - ISO 10993-7-2008 Download |
Jan 19, 2022 | 2197 | patent_own | Ex. 2197 - Eylea PFS Label Aug 2019 Download |
Jan 18, 2022 | 2198 | patent_own | Ex. 2198 - Venook Declaration Download |
Jan 18, 2022 | 2199 | patent_own | Ex. 2199 - ISO 11137 Download |
Jan 18, 2022 | 2200 | patent_own | Ex. 2200 - Von Woedtke and Kramer Download |
Jan 19, 2022 | 2201 | patent_own | Ex. 2201 - Supplemental Leinsing [Public Redacted Version] Download |
Jan 18, 2022 | 2202 | patent_own | Ex. 2202 - Declaration of John E. Dillberger Download |
Jan 19, 2022 | 2203 | patent_own | Ex. 2203 - Declaration of Michael J Miller [Public Redacted Version] Download |
Jan 19, 2022 | 2204 | patent_own | Ex. 2204 - Calman Declaration [Public Redacted Version] Download |
Jan 19, 2022 | 2205 | patent_own | Ex. 2205 - Malackowski Declaration [Public Redacted Version] Download |
Jan 19, 2022 | 2206 | patent_own | Ex. 2206 - Declaration of Juergen Sigg [Public Redacted Version] Download |
Jan 20, 2022 | 2208 | patent_own | Download |
Jan 18, 2022 | 2209 | patent_own | Ex. 2209 - Wolfe Declaration Download |
Jan 18, 2022 | 2210 | patent_own | Ex. 2210 - Curriculum Vitae of Dr. Kimberly Cameron Download |
Jan 18, 2022 | 2211 | patent_own | Ex. 2211 - Curriculum Vitae of Dr. Jeremy Wolfe Download |
Jan 18, 2022 | 2212 | patent_own | Ex. 2212 - Eylea Label 2021 Download |
Jan 18, 2022 | 2213 | patent_own | Ex. 2213 - Lucentis Label 2017 Download |
Jan 18, 2022 | 2214 | patent_own | Ex. 2214 - Chaturvedi Download |
Jan 18, 2022 | 2215 | patent_own | Ex. 2215 - Storey et al. 2019 Download |
Jan 18, 2022 | 2218 | patent_own | Ex. 2218 - Cilurzo Injectability Evaluation 2011 Download |
Jan 18, 2022 | 2222 | patent_own | Ex. 2222 - Summary of EU Product Characteristics, Lucentis PFS Download |
Jan 18, 2022 | 2224 | patent_own | Ex. 2224 - DSR5092D [PUBLIC REDACTED VERSION] Download |
Jan 18, 2022 | 2227 | patent_own | Ex. 2227 - Application No. 13/750,352 Download |
Jan 18, 2022 | 2228 | patent_own | Download |
Jan 18, 2022 | 2229 | patent_own | Ex. 2229 - Rathore 2011 Download |
Jan 18, 2022 | 2230 | patent_own | Ex. 2230 - EU Q5C Download |
Jan 18, 2022 | 2231 | patent_own | Ex. 2231 - EYLEA Approval Letter Download |
Jan 18, 2022 | 2232 | patent_own | Ex. 2232 - Freund 2006 Download |
Jan 18, 2022 | 2253 | patent_own | Ex. 2253 - Jones 2005 Download |
Jan 19, 2022 | 2254 | patent_own | Ex. 2254 - NOVITC(CH)00885630 [Public Redacted Version] Download |
Jan 18, 2022 | 2255 | patent_own | Ex. 2255 - Teng 2012 Download |
Jan 18, 2022 | 2256 | patent_own | Ex. 2256 - Calman CV Download |
Jan 19, 2022 | 2257 | patent_own | Ex. 2257 - Kiss Depo Tr. Download |
Jan 19, 2022 | 2258 | patent_own | Ex. 2258 - Macular Degeneration Treatments Download |
Jan 19, 2022 | 2259 | patent_own | Ex. 2259 - Avastin Prescribing Information Part 4 of 4 Download |
Jan 19, 2022 | 2259 | patent_own | Ex. 2259 - Avastin Prescribing Information Part 1 of 4 Download |
Jan 19, 2022 | 2259 | patent_own | Ex. 2259 - Avastin Prescribing Information Part 3 of 4 Download |
Jan 19, 2022 | 2259 | patent_own | Ex. 2259 - Avastin Prescribing Information Part 2 of 4 Download |
Jan 19, 2022 | 2260 | patent_own | Ex. 2260 - Comparison of Anti VEGF Treatments Download |
Jan 19, 2022 | 2261 | patent_own | Ex. 2261 - Age-Related Macular Degeneration Facts & Figures Download |
Jan 19, 2022 | 2262 | patent_own | Ex. 2262 - FDA Approves Avastin Article Download |
Jan 19, 2022 | 2264 | patent_own | Ex. 2264 - Roche March 22, 2018 Investor Update Download |
Jan 19, 2022 | 2265 | patent_own | Ex. 2265 - Genentech, Inc. Form 10K for the period ending 12312003 Download |
Jan 19, 2022 | 2266 | patent_own | Ex. 2266 - FDA Approves Lucentis Article Download |
Jan 19, 2022 | 2269 | patent_own | Ex. 2269 - FDA Approves Eylea Article Download |
Jan 19, 2022 | 2270 | patent_own | Ex. 2270 - FDA Approves Eylea PFS Article Download |
Jan 19, 2022 | 2271 | patent_own | Ex. 2271 - Prefilled Syringe Delivery of Intravitreal Anti-VEGF Medications Download |
Jan 19, 2022 | 2272 | patent_own | Ex. 2272 - Excerpted Chris Simms Transcript Download |
Jan 19, 2022 | 2273 | patent_own | Ex. 2273 - Roche Finance Report for 2011 Download |
Jan 19, 2022 | 2274 | patent_own | Ex. 2274 - Roche Finance Report for 2012 Part 2 of 2 Download |
Jan 19, 2022 | 2274 | patent_own | Ex. 2274 - Roche Finance Report for 2012 Part 1 of 2 Download |
Jan 19, 2022 | 2275 | patent_own | Ex. 2275 - Roche Finance Report for 2015 Part 2 of 2 Download |
Jan 19, 2022 | 2275 | patent_own | Ex. 2275 - Roche Finance Report for 2015 Part 1 of 2 Download |
Jan 19, 2022 | 2276 | patent_own | Ex. 2276 - Roche Finance Report for 2017 Part 3 of 3 Download |
Jan 19, 2022 | 2276 | patent_own | Ex. 2276 - Roche Finance Report for 2017 Part 2 of 3 Download |
Jan 19, 2022 | 2276 | patent_own | Ex. 2276 - Roche Finance Report for 2017 Part 1 of 3 Download |
Jan 19, 2022 | 2277 | patent_own | Ex. 2277 - Treatments for Wet AMD Download |
Jan 18, 2022 | 2278 | patent_own | Download |
Jan 18, 2022 | 2279 | patent_own | Ex. 2279 - Macugen European Medicines Agency - EPAR website Download |
Jan 18, 2022 | 2280 | patent_own | Ex. 2280 - Michaud 2014 Download |
Jan 18, 2022 | 2281 | patent_own | Ex. 2281 - Krzystolik 2002 Download |
Jan 18, 2022 | 2282 | patent_own | Ex. 2282 - FDA Approval for Macugen Download |
Jan 18, 2022 | 2283 | patent_own | Ex. 2283 - FDA Approved Drugs Page for Macugen Download |
Jan 18, 2022 | 2284 | patent_own | Ex. 2284 - Rich 2006 Download |
Jan 18, 2022 | 2285 | patent_own | Ex. 2285 - Avastin FDA Label Download |
Jan 18, 2022 | 2286 | patent_own | Ex. 2286 - Eylea FDA approval letter Download |
Jan 18, 2022 | 2287 | patent_own | Ex. 2287 - Federman 1998 Download |
Jan 18, 2022 | 2288 | patent_own | Ex. 2288 - Nguyen 1992 Download |
Jan 18, 2022 | 2289 | patent_own | Ex. 2289 - Scott 2003 Download |
Jan 18, 2022 | 2291 | patent_own | Ex. 2291 - Rosenberg 2006 Download |
Jan 18, 2022 | 2292 | patent_own | Ex. 2292 - Charles 2009 Download |
Jan 18, 2022 | 2293 | patent_own | Ex. 2293 - Stepien 2009 Download |
Jan 18, 2022 | 2294 | patent_own | Ex. 2294 - Beovu approval letter Download |
Jan 18, 2022 | 2295 | patent_own | Ex. 2295 - Mittra 2006 Download |
Jan 18, 2022 | 2296 | patent_own | Ex. 2296 - Santaella 2007 Download |
Jan 18, 2022 | 2297 | patent_own | Ex. 2297 - Abbasi 2009 Download |
Jan 18, 2022 | 2298 | patent_own | Ex. 2298 - Schatz 1986 Download |
Jan 18, 2022 | 2299 | patent_own | Ex. 2299 - Peck 2010 Download |
Jan 19, 2022 | 2300 | patent_own | Ex. 2300 - Yoon 2009 Download |
Jan 18, 2022 | 2301 | patent_own | Ex. 2301 - Lang 2007 Download |
Jan 18, 2022 | 2302 | patent_own | Ex. 2302 - Chen 2013 Download |
Jan 18, 2022 | 2303 | patent_own | Ex. 2303 - Sarao 2014 Download |
Jan 18, 2022 | 2304 | patent_own | Ex. 2304 - Baudin 2018 Download |
Jan 18, 2022 | 2305 | patent_own | Ex. 2305 - Wilson 2013 Download |
Jan 18, 2022 | 2306 | patent_own | Ex. 2306 - Kamjoo 2021 Download |
Jan 18, 2022 | 2307 | patent_own | Ex. 2307 - Jonas 2003 Download |
Jan 18, 2022 | 2308 | patent_own | Ex. 2308 - Ramulu 2010 Download |
Jan 18, 2022 | 2309 | patent_own | Ex. 2309 - Asbell 2016 Download |
Jan 18, 2022 | 2310 | patent_own | Ex. 2310 - EVS Study Group 1995 Download |
Jan 18, 2022 | 2311 | patent_own | Ex. 2311 - Dossarps 2015 Download |
Jan 18, 2022 | 2312 | patent_own | Ex. 2312 - Klein 2009 Download |
Jan 18, 2022 | 2313 | patent_own | Ex. 2313 - Green Simms 2011 Download |
Jan 18, 2022 | 2314 | patent_own | Ex. 2314 - McCannell 2011 Download |
Jan 18, 2022 | 2315 | patent_own | Ex. 2315 - Shimada 2013 Download |
Jan 18, 2022 | 2316 | patent_own | Ex. 2316 - Levinson 2018 Download |
Jan 18, 2022 | 2317 | patent_own | Ex. 2317 - Gallemore 2006 Download |
Jan 18, 2022 | 2318 | patent_own | Ex. 2318 - Ip 2004 Download |
Jan 18, 2022 | 2319 | patent_own | Ex. 2319 - Gedde 2006 Download |
Jan 18, 2022 | 2320 | patent_own | Ex. 2320 - Riedel 1990 Download |
Jan 18, 2022 | 2321 | patent_own | Ex. 2321 - Thompson 2021 Download |
Jan 18, 2022 | 2322 | patent_own | Ex. 2322 - Kahook 2010 Download |
Jan 18, 2022 | 2323 | patent_own | Ex. 2323 - Second Modified Protective Order Download |
Jan 18, 2022 | 2324 | patent_own | Ex. 2324 - Redline of Second Modified Protective Order Download |
Jan 18, 2022 | 2325 | patent_own | Ex. 2325 - Declaration of Martina Athanas Download |
Jan 18, 2022 | 2326 | patent_own | Ex. 2326 - FDA Eylea PFS Approval Letter Download |
Mar 3, 2022 | 2330 | patent_own | Ex. 2330 - Order appointing Swiss Commissioners, International Trade Commission Inv. No. 337-1207, Certain Pre-Filled Syringes for Intravitreal Injection and Components Thereof Download |
Mar 3, 2022 | 2331 | patent_own | Ex. 2331 - Order appointing Swiss Commissioners, Novartis Pharma AG et al v. Regeneron Pharmaceuticals, Inc., No. 1:20-cv00690-DH-CFH (NDNY) Download |
Mar 3, 2022 | 2332 | patent_own | Ex. 2332 - Proposed Order Appointing Commissioners Download |
Mar 24, 2022 | 2333 | patent_own | Download |
Mar 24, 2022 | 2334 | patent_own | Ex. 2334 - Declaration of Daniel P. Margolis in Support of Patent Owners Motion for Pro Hac Vice Admission of Daniel P. Margolis Under 37 C.F.R. 42.10 (c) Download |
May 11, 2022 | 2335 | patent_own | Akers and Agalloco 2013, Overcoming Limitations of Vaporized Hydrogen Peroxide Download |
May 11, 2022 | 2336 | patent_own | Agalloco 2008, Chapter in Pharmaceutical Manufacturing Handbook Download |
May 26, 2022 | 2339 | patent_own | Deposition Transcript of James Agalloco (May 4, 2022) [Redacted Version] Download |
May 26, 2022 | 2340 | patent_own | Deposition Transcript of Joel M. Cohen (May 19, 2022) Download |
May 26, 2022 | 2345 | patent_own | Deposition Transcript of Szilard Kiss, M.D., Vol. 2 (May 13, 2022) [Redacted Version] Download |
May 26, 2022 | 2347 | patent_own | Deposition Transcript of Horst Koller, Vol. 2 (May 16, 2022) [Redacted Version] Download |
Aug 27, 2021 | 3001 | board | E-Mail Download |
May 25, 2022 | 3002 | board | Exhibit 3002 Download |